BOLT vs L · rev $7.7M vs P/E 14, rev $18.45B
Bolt Biotherapeutics (BOLT) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
BOLT currently screens at market cap $11.3M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the BOLT and L stock pages for the full models.
Not investment advice.